A Study of the Effects of Exercise Intensity on Insulin Sensitivity in Overweight Youth
POWER
Physical Activity for Overweight Youth at Risk for Type 2 Diabetes Mellitus (POWER) Trial
2 other identifiers
interventional
120
1 country
1
Brief Summary
Background: The investigators know that exercise helps children develop strong bones and muscles and generally stay healthy. What is unclear however, is how much exercise a child needs to lower their risk of developing type 2 diabetes. Objective: The investigators will try to find out whether high-intensity exercise for a short-period of time is better than moderately intense exercise for improving the diabetes risk profile in teens who are at risk for type 2 diabetes. The working hypothesis is that exercise-mediated improvements in insulin sensitivity (a risk factor for diabetes) will be greater following vigorous intermittent physical activity than following low intensity physical activity in overweight adolescents 13-18 yrs at risk for T2DM. Brief Description of Research Project: Teenagers between the ages of 13 and 18 yrs, who are at risk for type 2 diabetes (either by their family history or an abnormal response to sugar) will be randomly assigned to one of two activity groups or a control group. The activity groups will have supervised exercise sessions 3 to 5 days per week for 6 months. One group will do high-intensity exercise, and the other will do lower-intensity exercise. We will measure how sensitive their body is to insulin and the amount of fat in their muscle and liver tissue at the beginning and end of the exercise intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4 type-2-diabetes-mellitus
Started Apr 2008
Longer than P75 for phase_4 type-2-diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2008
CompletedFirst Submitted
Initial submission to the registry
September 18, 2008
CompletedFirst Posted
Study publicly available on registry
September 19, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2013
CompletedMarch 29, 2013
March 1, 2013
4.8 years
September 18, 2008
March 27, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Insulin sensitivity measured from Bergman's frequently sampled intravenous glucose tolerance test
6 months
Secondary Outcomes (1)
1H-Magnetic resonance spectroscopy-derived measure of lipid content in liver and muscle tissue
6 months
Study Arms (3)
High Intensity
EXPERIMENTAL70-85% of peak oxygen uptake for 30 min 3-5 days/week.
Low Intensity
EXPERIMENTAL40-55% of peak oxygen uptake for 60 min 3-5 days/week
Sedentary Control
NO INTERVENTIONRegular activities of daily living for 6 months
Interventions
All sessions will be designed to elicit a certain degree of energy expenditure that will progressively increase throughout the trial. Adolescents randomized to the vigorous activity group will perform interval sessions that ensure an average heart rate between 70 and 85% of maximal heart rate reserve while those randomized will perform aerobic activity between 40 and 50% of heart rate reserve. The goal for the trial will be to expend a minimum of 350 kcal. The type of exercise will depend on the preference of each participant however, during the supervised sessions walking/jogging on a treadmill or outdoors will be used to elicit exercise intensities. The three activity sessions held at the YMCA-YWCA facilities in Winnipeg and be supervised by a trained kinesiologist who will record heart rate and perceived exertion for each session.
Eligibility Criteria
You may qualify if:
- Ethnic minority considered at risk for T2DM
- In utero exposure to hyperglycemia (i.e. mother with gestational or frank diabetes during pregnancy) and/or evidence of hepatic steatosis (serum ALT \> 60U/L, ultrasound or MRI-based evidence of steatosis).
You may not qualify if:
- The investigators will exclude any patients that may have altered insulin sensitivity or tissue lipid content that would confound (mask) the effects of the intervention.
- These include overweight adolescents who:
- are diagnosed with impaired glucose tolerance or type 2 diabetes
- are currently being treated with corticosteroids or atypical antipsychotics, as these agents significantly influence carbohydrate metabolism
- are undergoing puberty (Tanner Stage 2-4) at the time of the investigation, as it is associated with transient changes in insulin sensitivity
- have an orthopaedic injury that would prevent them from performing the intervention
- have experienced weight loss or enrolled in weight loss program in the six months prior to the study
- have a history of alcoholism or drug abuse.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Manitobalead
- Manitoba Institute of Child Healthcollaborator
Study Sites (1)
Manitoba Institute of Child Health
Winnipeg, Manitoba, R3E3P4, Canada
Related Publications (2)
Hrubeniuk TJ, Hay JL, MacIntosh AC, Wicklow B, Wittmeier K, McGavock JM, Senechal M. Interindividual variation in cardiometabolic health outcomes following 6 months of endurance training in youth at risk of type 2 diabetes mellitus. Appl Physiol Nutr Metab. 2021 Jul;46(7):727-734. doi: 10.1139/apnm-2020-0707. Epub 2021 Feb 5.
PMID: 33544653DERIVEDMollard RC, Senechal M, MacIntosh AC, Hay J, Wicklow BA, Wittmeier KD, Sellers EA, Dean HJ, Ryner L, Berard L, McGavock JM. Dietary determinants of hepatic steatosis and visceral adiposity in overweight and obese youth at risk of type 2 diabetes. Am J Clin Nutr. 2014 Apr;99(4):804-12. doi: 10.3945/ajcn.113.079277. Epub 2014 Feb 12.
PMID: 24522441DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jonathan M McGavock, PhD
University of Manitoba
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 18, 2008
First Posted
September 19, 2008
Study Start
April 1, 2008
Primary Completion
January 1, 2013
Study Completion
January 1, 2013
Last Updated
March 29, 2013
Record last verified: 2013-03